Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 15, 2024

Rhea-AI Summary

Organon, a global healthcare company focusing on women's health, will release its Q4 and full year 2023 financial results on February 15, 2024. The company will host a webcast and conference call at 8:30 a.m. EST. Interested parties can access the live call via webcast and a replay will be available on the company's website. Institutional investors and analysts must register in advance to participate.

JERSEY CITY, N.J.--(BUSINESS WIRE)-- Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, will release its fourth quarter and full year 2023 financial results on February 15, 2024, prior to the company’s webcast and conference call scheduled for 8:30 a.m. EST.

Interested parties may access the live call via webcast on the Organon website at https://www.organon.com/investor-relations/events-and-presentations/. A replay of the webcast will be available approximately two hours after the conclusion of the live event on the company’s website.

Institutional investors and analysts interested in participating in the call must register in advance by clicking on this link: https://conferencingportals.com/event/VfCOQYEG

Following registration, participants will receive a confirmation email containing details on how to join the conference call, including dial-in information and a unique passcode and registrant ID. Pre-registration will allow participants to bypass an operator and be placed directly into the call.

About Organon

Organon is a global healthcare company formed to focus on improving the health of women throughout their lives. Organon offers more than 60 medicines and products in women’s health in addition to a growing biosimilars business and a large franchise of established medicines across a range of therapeutic areas. Organon’s existing products produce strong cash flows that support investments in innovation and future growth opportunities in women’s health and biosimilars. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialize their products by leveraging its scale and presence in fast growing international markets.

Organon has a global footprint with significant scale and geographic reach, world-class commercial capabilities, and approximately 10,000 employees with headquarters located in Jersey City, New Jersey.

For more information, visit http://www.organon.com and connect with us on LinkedIn, Instagram, X (formerly known as Twitter) and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240201504170/en/

Organon Media Contacts:

Karissa Peer

(614) 314-8094

Kate Vossen

(732) 675-8448

Organon Investor Contacts:

Jennifer Halchak

(201) 275-2711

Alex Arzeno

(203) 550-3972

Source: Organon & Co.

FAQ

When will Organon release its Q4 and full year 2023 financial results?

Organon will release its Q4 and full year 2023 financial results on February 15, 2024.

What is the focus area of Organon?

Organon focuses on women's health.

How can interested parties access the live call?

Interested parties can access the live call via webcast on the Organon website.

How can institutional investors and analysts participate in the call?

Institutional investors and analysts must register in advance to participate in the call.